Work Here?
Overview
e184 is a venture capital investor focusing on HealthTech, FinTech, and SaaS in the United States, providing capital to startups to help them grow. It uses a multi-stage VC model, investing equity across early to late stages and aiming for exits such as IPOs or acquisitions, guided by leadership that coordinates capital allocation and leverages expertise in payments, banking, crypto, and investments. The firm differentiates itself through its sector focus combined with flexible stages and a willingness to explore additional verticals, using its payments, banking, and crypto know-how to guide portfolio value. Its goal is to deliver high-growth returns for investors by funding innovative startups, supporting their scale, and exiting positions profitably, while continually seeking new opportunities across industries.
About e184
Industries
Venture Capital
Enterprise Software
Fintech
Healthcare
Company Size
1-10
Company Stage
N/A
Total Funding
$5.8M
Headquarters
Kentucky
Founded
2023
Simplify's Take
What believers are saying
- Paterna BioSciences $6M seed round October 2024 validates e184's reproduction thesis and IVS market potential.[3][4]
- SpringTide Ventures partnership in HealthTech opens co-investment synergies across digital health and life sciences.[3]
- Neurotech moonshot program attracts entrepreneurial scientists seeking patient capital for long-horizon BMI development.[7]
What critics are saying
- SpringTide Ventures leads Paterna round while e184 participates secondarily, reducing deal influence and returns.[3][4]
- FDA approval delays for IVS technology post-2025 trials block portfolio exits and capital returns.[4][5]
- Neuralink's rapid BMI advancement captures top talent and funding, starving e184's neurotech pipeline.[7]
What makes e184 unique
- Multi-stage investor across HealthTech, FinTech, SaaS with deep sector expertise in payments, banking, crypto.[1][2]
- Proprietary portfolio companies e184 BAI and e184 Repro-IVG provide direct exposure to neuroscience and reproduction.[1]
- ARPA-inspired approach to neurotech moonshots emphasizes general-purpose tech over near-term applications.[7]
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$5.8M
Above
Industry Average
Funded Over
0 Rounds
Benefits
Health Insurance
401(k) Retirement Plan
Paid Vacation
Remote Work Options
Flexible Work Hours
Wellness Program
Mental Health Support
Conference Attendance Budget
Professional Development Budget
Stock Options
Equity
Company News
$6 million oversubscribed seed investment to advance pioneering in vitro spermatogenesis science, offers new hope for people struggling with infertility.
e184 is Hiring for 5 Jobs on Simplify!
Find jobs on Simplify and start your career today
About e184
Industries
Venture Capital
Enterprise Software
Fintech
Healthcare
Company Size
1-10
Company Stage
N/A
Total Funding
$5.8M
Headquarters
Kentucky
Founded
2023
e184 is Hiring for 5 Jobs on Simplify!
Find jobs on Simplify and start your career today